Literature DB >> 7894963

Natural history of viral hepatitis, type C.

L B Seeff1.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7894963

Source DB:  PubMed          Journal:  Semin Gastrointest Dis        ISSN： 1049-5118


× No keyword cloud information.
  11 in total

Review 1.  The quasispecies of hepatitis C virus and the host immune response.

Authors:  P Farci; J Bukh; R H Purcell
Journal:  Springer Semin Immunopathol       Date:  1997

2.  Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection.

Authors:  P H McGuinness; D Painter; S Davies; G W McCaughan
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

3.  Usefulness of a liver biopsy in the evaluation of patients with elevated ALT values and serological markers of hepatitis viral infection: an AIGO study.

Authors:  A Andriulli; V Festa; G Leandro; M Rizzetto
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

4.  Comparative features of hepatitis C virus infection in humans and chimpanzees.

Authors:  C M Walker
Journal:  Springer Semin Immunopathol       Date:  1997

Review 5.  HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?

Authors:  J T Blackard; K E Sherman
Journal:  J Viral Hepat       Date:  2008-01-17       Impact factor: 3.728

6.  Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus.

Authors:  Aihua Zheng; Fei Yuan; Yanqin Li; Fangfang Zhu; Pingping Hou; Jianqing Li; Xijun Song; Mingxiao Ding; Hongkui Deng
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

7.  In vitro resistance study of AG-021541, a novel nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Stephanie T Shi; Koleen J Herlihy; Joanne P Graham; Shella A Fuhrman; Chau Doan; Hans Parge; Michael Hickey; Jingjin Gao; Xiu Yu; Fannie Chau; Javier Gonzalez; Hui Li; Cristina Lewis; Amy K Patick; Rohit Duggal
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

8.  Preclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Stephanie T Shi; Koleen J Herlihy; Joanne P Graham; Jim Nonomiya; Sadayappan V Rahavendran; Heather Skor; Rebecca Irvine; Susan Binford; John Tatlock; Hui Li; Javier Gonzalez; Angelica Linton; Amy K Patick; Cristina Lewis
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

9.  Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization.

Authors:  Jason T Blackard; Gang Ma; Jeffrey A Welge; Christina M Martin; Kenneth E Sherman; Lynn E Taylor; Kenneth H Mayer; Denise J Jamieson
Journal:  J Med Virol       Date:  2012-02       Impact factor: 2.327

10.  Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors.

Authors:  Koleen J Herlihy; Joanne P Graham; Robert Kumpf; Amy K Patick; Rohit Duggal; Stephanie T Shi
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.